BioHarvest Sciences Inc. (Nasdaq: BHST) is a public biotech company that has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial compounds in fruit & plants, at an industrial scale, without the need to grow the plant itself.
BioHarvest has invested 17 years and >$100M to develop our Botanical Synthesis Technology, which produces unique and patentable botanical compositions which contain a “target optimized” combination of the phyto-medicinal compounds (with high solubility and bio-availability) found in the original plant. No other company has developed a commercially viable plant cell culture platform at the industrial scale of BioHarvest.
BioHarvest is focused on leveraging this platform technology across the following business units:
1. Biologics+ CDMO Services: BioHarvest is leveraging its Botanical Synthesis technology to allow global pharmaceutical, nutrition, cosmetics, and nutraceutical partners to develop proprietary compounds with unmatched predictability and consistency, manufactured at industrial scale under exclusive partnerships.
2. Direct to Consumer Business Anchored in Science: BioHarvest has built its own direct to consumer business of propriety botanical compositions. The first product, VINIA® was launched into the US in 2021 and has now exceeded 60,000 daily users (>$50M USD Revenue since 2021 launch). VINIA® contains multiple polyphenols, including Piceid Resveratrol, with an amount in each daily 400mg capsule that is equivalent to 1,000 grapes, resulting in a powerful nutraceutical that has been clinically proven (in a published double-blind placebo-controlled study), to significantly increase dilation of arteries. This increased dilation of arteries improves blood flow and the delivery of oxygen and nutrients to the body, tissue & organs.
Ecosphere Technologies, Inc. (OTCQB: ESPH) is a technology development and intellectual property licensing company that develops environmental solutions for global water, energy, industrial and agricultural markets. We help industry increase production, reduce costs, and protect the environment through a portfolio of unique, patented technologies: technologies like Ozonix®, Cavisonix®, the Ecos PowerCube® and the Ecos GrowCube™, which are available for sale, as well as exclusive and nonexclusive licensing opportunities across a wide range of industries and applications throughout the world.
The Ecosphere technologies and products are available through multiple brands and subsidiaries that include Sea of Green Systems, Ecosphere Development Company and Fidelity National Environmental Solutions.
For more information, please visit www.EcosphereTech.com
For investor related inquiries or to stay informed of news and events, join Ecosphere's email list by visiting us at http://ir.stockpr.com/ecospheretech/request-information.
Greenway Biotech Inc. was founded in 1989 and headquartered in Santa Fe Springs, is one of California’s leading specialty chemical groups. Greenway Biotech Inc.’s products include Personal Care and Beauty, Organic Fertilizers, Water Soluble Fertilizers, Raw Chemicals and Compounds, and Specialty Fertilizers. At the core of our strategy is a resilient integrated model that encompasses the entire value chain of the agricultural and personal care commodity processing business, from origination and processing to branding, merchandising and distribution of a wide range of chemical products. Greenway Biotech Inc.’s portfolio consists of only high quality chemicals without Heavy Metals and Harmful Chemicals. Its consumer packed products occupy a leading share in its targeted markets. Through scale, integration and the logistical advantages of its business model, Greenway Biotech, Inc. is able to extract margins at every step of the value chain, thereby reaping operational synergies and cost efficiencies. Greenway Biotech, Inc. remains a firm advocate of sustainable growth and is committed to its role as a responsible corporate citizen.